Dimpy Koul
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 21
- DNA Repair Mechanisms 6
- CRISPR and Genetic Engineering 6
- Oncology 18
- Cancer-related Molecular Pathways 6
- PARP inhibition in cancer therapy 6
- Co-authors
- W.K. Alfred Yung (26 shared papers)Peter A. Steck (5 shared papers)Gordon B. Mills (9 shared papers)Michael A. Davies (5 shared papers)Yiling Lu (6 shared papers)Shishir Shishodia (3 shared papers)Bharat B. Aggarwal (3 shared papers)Ruijun Shen (10 shared papers)
- Journals
- Neuro-Oncology (10 papers)Cancer Research (8 papers)Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (4 papers)Oncogene (3 papers)
- Partner nations
- United StatesMexicoAustralia
In The Last Decade
Dimpy Koul
63 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 104
- Genetics 755
- Cancer Research 785
- Molecular Biology 2.4k
- Oncology 774
- Immunology and Allergy 114
Countries citing papers authored by Dimpy Koul
This map shows the geographic impact of Dimpy Koul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimpy Koul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimpy Koul more than expected).
Fields of papers citing papers by Dimpy Koul
This network shows the impact of papers produced by Dimpy Koul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimpy Koul. The network helps show where Dimpy Koul may publish in the future.
Co-authors
The 25 scholars most cited alongside Dimpy Koul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 272 | |
| 2 | Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. | 1999 | 234 |
| 3 | 2003 | 224 | |
| 4 | Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. | 1999 | 221 |
| 5 | 2009 | 209 | |
| 6 | Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. | 1998 | 197 |
| 7 | 2008 | 174 | |
| 8 | 2004 | 169 | |
| 9 | 2004 | 168 | |
| 10 | 2011 | 137 | |
| 11 | 2013 | 114 | |
| 12 | 2010 | 108 | |
| 13 | 2021 | 103 | |
| 14 | 2004 | 88 | |
| 15 | 2000 | 88 | |
| 16 | 2005 | 87 | |
| 17 | 2008 | 86 | |
| 18 | 2006 | 79 | |
| 19 | 2013 | 78 | |
| 20 | 2001 | 78 |
About Dimpy Koul
Dimpy Koul is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 63 papers that have together received 3.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (21 papers), Glioma Diagnosis and Treatment (12 papers), Cancer Mechanisms and Therapy (8 papers), DNA Repair Mechanisms (6 papers), Cancer-related Molecular Pathways (6 papers), PARP inhibition in cancer therapy (6 papers), CRISPR and Genetic Engineering (6 papers) and NF-κB Signaling Pathways (5 papers). The work is most often cited by research in Genetics (755 citations), Cancer Research (785 citations), Molecular Biology (2.4k citations), Oncology (774 citations) and Immunology and Allergy (114 citations). Dimpy Koul has collaborated with scholars based in United States, Mexico and Australia. Frequent co-authors include W.K. Alfred Yung, Peter A. Steck, Gordon B. Mills, Michael A. Davies, Yiling Lu, Shishir Shishodia, Bharat B. Aggarwal, Ruijun Shen, W.K. Alfred Yung and Tiffany A. LaFortune. Their work appears in journals such as Neuro-Oncology, Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.